Stockton, California/December 3, 2012/Newswire/ Viratech Corp. (OTC:VIRA) and Newswire are proud to announce that the first episode of “This Week in Viratech” has been released. The episode can be viewed at http://www.youtube.com/watch?v=YsZk_FF2jtY&feature=youtu.be and explains in depth the appointment of Dr. Kevin Buckman as the new CEO of Viratech, Corp, with a spotlight on his achievements including:
Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO completed his Medical School training at USC; he remained at USC for internship and 2nd year residency in Internal Medicine, and completed his training in Internal Medicine in 1981 at San Joaquin General Hospital, a UC Davis affiliate. He received Post Graduate Training at Stanford University School of Business, and attended seminars with the Securities Exchange Institute. He began his research in 1977 in the field of immunology, cancer, diabetes, and chronic diseases. His discovery of the role of Inflammation and Abnormal Cellular Environment in Cancer and immune disease in the 70’s has made him a leader in the field. His continuous research in this field has lead to his technologies in Non-Harmful Medicine with Early Diagnosis and Treatments, especially in the field of Women’s Health. He has published books including Find and Stop Breast Cancer, and Find and Stop Diabetes. He was recently a Speaker and Exhibitor at the International Cancer Conference and Forum 2010, in Seoul, Korea, where he addressed many women’s health issues and solutions.
Dr. Buckman has served as Medical Director in various hospitals and institutions for over 25 years and has over 35 years of clinical experience. He has served as a member of the Executive Committee for six years at St. Dominic’s Hospital in Manteca, California. He has written many patents for new medical technologies. From 1986 to 1997 there were more than 50 Physicians under his direction at various institutions and hospitals. He also served as Medical Director for Dameron Hospital EMS Liaison from 2002 to 2003. He became Board Certified in Emergency Medicine and a Fellow of the American Board of Emergency Medicine in 1990.
Dr. Buckman has received numerous Certifications and specialty training in the field of Medicine. He is a Fellow in the American Association of Integrated Medicine, and a certified Medical Review Officer. His other specialties include: Internal Medicine, Forensic Medicine, Chinese Medicine and Acupuncture. He has over three decades of hospital and clinical experience and has served on over 15 hospital committees. He became Board Certified in Urgent Care Medicine and a Diplomate in 2006.
Dr. Buckman has presented research, published articles and books in the field of medicine, has exhibited breast cancer technologies, and given lectures at numerous hospitals and at International Medical Conferences, has exhibited Breast Cancer technologies.
Dr. Buckman serves on the Board of Directors for the California College of Natural Medicine. He was the first U.S. physician to be accepted into the European Group for Breast Cancer Screening after his research in this field was accepted for publication and presentation at their international conference in Cyprus. For many years he has worked internationally to advance a number of medical technologies. He has had a special interest in non-harmful early detection of disease, with a primary focus on Breast Cancer and Diabetes, his research in the field preventive medicine, and his expertise in non-harmful new methods of medical treatment for cancer. His most recent Breast Cancer work was published at the International Cancer Conference and Forum 2010, in Seoul, Korea. He is currently serving on the Industry Advisory Board for the University of Pacific School of Engineering and Computer Science and a Visiting Professor in Bioengineering, University of Pacific School of Engineering and Computer Science.
Dr. John Stein
Dr. Stein has been involved in numerous prospective and randomized trials of drug as well as technology implementations in the acute care environment. He received his Medical Degree from Dartmouth Medical School where he was elected into the Syvertsen Scholarship, received the Merck Manual Award, and graduated in the Alpha Omega Alpha Medical Honors Society. He pursued clinical training at the Alameda County Medical Center’s Highland Hospital, one of the most competitive residency training programs in Emergency Medicine. Since that time he has been on the faculty at UCSF, and has assumed a number of roles aside from research including directing the Emergency Ultrasound Department, and acting as one of the medical school’s eight Advisory College Mentors.
Dr. Stein has recently received a K-08 award from the Agency for Research and Quality which aimed to validate the training guidelines for emergency ultrasound as they pertain to the evaluation of ectopic pregnancy. As part of that four year grant, he completed his Masters in Clinical Research through the university’s Clinical and Translational Sciences Institute, and he was also elected to the K Scholars group where he served from 2007-2011.
He has published manuscripts on over 20 prospective trials among a variety of other writings. He also has extensive background with industry and foundation partners, and has received grants from the California Healthcare Foundation as well as the Fujitsu Corporation.
Dr. Valerie Kidd
Dr. Kidd’s work for many years in primary care allows her to understand the importance of early detection of disease and need to improve medical care, and access to care. Her teaching experience adds to her credibility in the realm of Primary Care and she is a valuable asset to Viratech’s Board of Directors.
Dr. Kidd received her BA in Chemistry from UC Davis, College of Letters and Science in 1980. She received her MD at University of California at Irvine, College of Medicine in1984. She completed a Family Practice Residency Program at San Joaquin General Hospital from July 1984 to July 1987. She became first Board Certificated in Family Practice in 1987, then again in 1993, 2000, and 2007. Dr. Kidd is an active member of the American Academy of Family Physicians since 1987. She has been practicing medicine at Lodi Memorial Hospital since 2006. Since 2006, Dr. Kidd has held the following positions:
1987-1988, Staff Physician, Employee Health Services, San Joaquin General Hospital;
1988-1991, Staff Physician, Lincoln Family Medial Group, Douglas Road, Stockton;
1991-1995, Staff Physician, Employee Health Services, Modesto, Stanislaus County;
1995-1996, Physician, California State University Stanislaus Student Health Center;
1996-2006, Staff Physician, Employee Health Services Clinic, San Joaquin General Hospital;
2007-March 2009, Family Medicine Physician, St Joseph’s Medical Group of Stockton;
2007-March 2009, Medical Director, University of Pacific, Cowell Wellness Center Student Health;
2006-present, Staff Physician, Lodi Memorial Hospital Urgent Care Clinic;
2006-present, Staff Physician, Lodi Memorial Occupational Med Clinic;
Teaching Positions:
1988-2003, University of Pacific, Physical Therapy Guest Lecturer;
1987-1991, Clinical Preceptor, San Joaquin Family Practice Residency;
1991-1996, Clinic Preceptor, Stanislaus Family Practice Residency;
1996-2003, Clinic Preceptor, San Joaquin Family Practice Residency.
Dr. Aziz Kamali
Dr. Kamali is the Founder of the Omar Kamali Medical Center in Afghanistan. This hospital is a new facility with 350 beds and plans for expansion to serve many more patients. It is part of AHERO, Afghanistan’s Health Education and Reconstruction Organization, which was founded by Dr. Kamali, and can be found on the web at www.aHero.org.
Dr. Kamali was born and raised in Jalalabad, in eastern Afghanistan. He obtained his secondary education in Kabul and did his undergraduate studies at the University of Afghanistan in Kabul.
Dr. Kamali comes from a large family of medical, legal and engineering professionals who have been very active with the current development of Afghanistan, following in the footsteps of their father, Mohammed Shirin Kamali, a judge in eastern Afghanistan. Dr. Kamali is a diplomate of the American Board of Internal Medicine.
Dr. Kamali is an associate clinical professor at the University of California, Davis, School of Medicine, in Sacramento, California. He did his postgraduate training in England and has a full registration with the British General Medical Council. He is a Fellow of the American College of Physicians and an Associate Fellow of American College of Cardiology.
“I am pleased to accept the appointment to Viratech’s Board of Directors,” said Dr. Kamali. I look forward to the innovations in open source medical research that will bring medical technology into the 21st Century,” he added.
Tutorial Videos
Tutorial videos were released, in order to assist our open source development partners. Viratech has released a 30 part tutorial based system to help accelerate the understanding our new toolset. The videos appear at: http://viratech.org/s/pageitem/videointros. Says Dr. Kevin Buckman, CEO and founder of Viratech, “The videos explain everything, from how to use the site, to the Company’s unique activity point system, to assist the user in protecting intellectual property, promoting open source research, and commercial development of new diagnostics and therapies.”
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.
Forward-Looking Statements:
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact : Dr. Kevin Buckman, CEO
Viratech Corp.
Email Contact: info@viratech.org
Stockton, California/December 3, 2012/Newswire/ Viratech Corp. (OTC:VIRA) and Newswire are proud to announce that the first episode of “This Week in Viratech” has been released. The episode can be viewed at http://www.youtube.com/watch?v=YsZk_FF2jtY&feature=youtu.be and explains in depth the appointment of Dr. Kevin Buckman as the new CEO of Viratech, Corp, with a spotlight on his achievements including:
Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO completed his Medical School training at USC; he remained at USC for internship and 2nd year residency in Internal Medicine, and completed his training in Internal Medicine in 1981 at San Joaquin General Hospital, a UC Davis affiliate. He received Post Graduate Training at Stanford University School of Business, and attended seminars with the Securities Exchange Institute. He began his research in 1977 in the field of immunology, cancer, diabetes, and chronic diseases. His discovery of the role of Inflammation and Abnormal Cellular Environment in Cancer and immune disease in the 70’s has made him a leader in the field. His continuous research in this field has lead to his technologies in Non-Harmful Medicine with Early Diagnosis and Treatments, especially in the field of Women’s Health. He has published books including Find and Stop Breast Cancer, and Find and Stop Diabetes. He was recently a Speaker and Exhibitor at the International Cancer Conference and Forum 2010, in Seoul, Korea, where he addressed many women’s health issues and solutions.
Dr. Buckman has served as Medical Director in various hospitals and institutions for over 25 years and has over 35 years of clinical experience. He has served as a member of the Executive Committee for six years at St. Dominic’s Hospital in Manteca, California. He has written many patents for new medical technologies. From 1986 to 1997 there were more than 50 Physicians under his direction at various institutions and hospitals. He also served as Medical Director for Dameron Hospital EMS Liaison from 2002 to 2003. He became Board Certified in Emergency Medicine and a Fellow of the American Board of Emergency Medicine in 1990.
Dr. Buckman has received numerous Certifications and specialty training in the field of Medicine. He is a Fellow in the American Association of Integrated Medicine, and a certified Medical Review Officer. His other specialties include: Internal Medicine, Forensic Medicine, Chinese Medicine and Acupuncture. He has over three decades of hospital and clinical experience and has served on over 15 hospital committees. He became Board Certified in Urgent Care Medicine and a Diplomate in 2006.
Dr. Buckman has presented research, published articles and books in the field of medicine, has exhibited breast cancer technologies, and given lectures at numerous hospitals and at International Medical Conferences, has exhibited Breast Cancer technologies.
Dr. Buckman serves on the Board of Directors for the California College of Natural Medicine. He was the first U.S. physician to be accepted into the European Group for Breast Cancer Screening after his research in this field was accepted for publication and presentation at their international conference in Cyprus. For many years he has worked internationally to advance a number of medical technologies. He has had a special interest in non-harmful early detection of disease, with a primary focus on Breast Cancer and Diabetes, his research in the field preventive medicine, and his expertise in non-harmful new methods of medical treatment for cancer. His most recent Breast Cancer work was published at the International Cancer Conference and Forum 2010, in Seoul, Korea. He is currently serving on the Industry Advisory Board for the University of Pacific School of Engineering and Computer Science and a Visiting Professor in Bioengineering, University of Pacific School of Engineering and Computer Science.
Dr. John Stein
Dr. Stein has been involved in numerous prospective and randomized trials of drug as well as technology implementations in the acute care environment. He received his Medical Degree from Dartmouth Medical School where he was elected into the Syvertsen Scholarship, received the Merck Manual Award, and graduated in the Alpha Omega Alpha Medical Honors Society. He pursued clinical training at the Alameda County Medical Center’s Highland Hospital, one of the most competitive residency training programs in Emergency Medicine. Since that time he has been on the faculty at UCSF, and has assumed a number of roles aside from research including directing the Emergency Ultrasound Department, and acting as one of the medical school’s eight Advisory College Mentors.
Dr. Stein has recently received a K-08 award from the Agency for Research and Quality which aimed to validate the training guidelines for emergency ultrasound as they pertain to the evaluation of ectopic pregnancy. As part of that four year grant, he completed his Masters in Clinical Research through the university’s Clinical and Translational Sciences Institute, and he was also elected to the K Scholars group where he served from 2007-2011.
He has published manuscripts on over 20 prospective trials among a variety of other writings. He also has extensive background with industry and foundation partners, and has received grants from the California Healthcare Foundation as well as the Fujitsu Corporation.
Dr. Valerie Kidd
Dr. Kidd’s work for many years in primary care allows her to understand the importance of early detection of disease and need to improve medical care, and access to care. Her teaching experience adds to her credibility in the realm of Primary Care and she is a valuable asset to Viratech’s Board of Directors.
Dr. Kidd received her BA in Chemistry from UC Davis, College of Letters and Science in 1980. She received her MD at University of California at Irvine, College of Medicine in1984. She completed a Family Practice Residency Program at San Joaquin General Hospital from July 1984 to July 1987. She became first Board Certificated in Family Practice in 1987, then again in 1993, 2000, and 2007. Dr. Kidd is an active member of the American Academy of Family Physicians since 1987. She has been practicing medicine at Lodi Memorial Hospital since 2006. Since 2006, Dr. Kidd has held the following positions:
1987-1988, Staff Physician, Employee Health Services, San Joaquin General Hospital;
1988-1991, Staff Physician, Lincoln Family Medial Group, Douglas Road, Stockton;
1991-1995, Staff Physician, Employee Health Services, Modesto, Stanislaus County;
1995-1996, Physician, California State University Stanislaus Student Health Center;
1996-2006, Staff Physician, Employee Health Services Clinic, San Joaquin General Hospital;
2007-March 2009, Family Medicine Physician, St Joseph’s Medical Group of Stockton;
2007-March 2009, Medical Director, University of Pacific, Cowell Wellness Center Student Health;
2006-present, Staff Physician, Lodi Memorial Hospital Urgent Care Clinic;
2006-present, Staff Physician, Lodi Memorial Occupational Med Clinic;
Teaching Positions:
1988-2003, University of Pacific, Physical Therapy Guest Lecturer;
1987-1991, Clinical Preceptor, San Joaquin Family Practice Residency;
1991-1996, Clinic Preceptor, Stanislaus Family Practice Residency;
1996-2003, Clinic Preceptor, San Joaquin Family Practice Residency.
Dr. Aziz Kamali
Dr. Kamali is the Founder of the Omar Kamali Medical Center in Afghanistan. This hospital is a new facility with 350 beds and plans for expansion to serve many more patients. It is part of AHERO, Afghanistan’s Health Education and Reconstruction Organization, which was founded by Dr. Kamali, and can be found on the web at www.aHero.org.
Dr. Kamali was born and raised in Jalalabad, in eastern Afghanistan. He obtained his secondary education in Kabul and did his undergraduate studies at the University of Afghanistan in Kabul.
Dr. Kamali comes from a large family of medical, legal and engineering professionals who have been very active with the current development of Afghanistan, following in the footsteps of their father, Mohammed Shirin Kamali, a judge in eastern Afghanistan. Dr. Kamali is a diplomate of the American Board of Internal Medicine.
Dr. Kamali is an associate clinical professor at the University of California, Davis, School of Medicine, in Sacramento, California. He did his postgraduate training in England and has a full registration with the British General Medical Council. He is a Fellow of the American College of Physicians and an Associate Fellow of American College of Cardiology.
“I am pleased to accept the appointment to Viratech’s Board of Directors,” said Dr. Kamali. I look forward to the innovations in open source medical research that will bring medical technology into the 21st Century,” he added.
Tutorial Videos
Tutorial videos were released, in order to assist our open source development partners. Viratech has released a 30 part tutorial based system to help accelerate the understanding our new toolset. The videos appear at: http://viratech.org/s/pageitem/videointros. Says Dr. Kevin Buckman, CEO and founder of Viratech, “The videos explain everything, from how to use the site, to the Company’s unique activity point system, to assist the user in protecting intellectual property, promoting open source research, and commercial development of new diagnostics and therapies.”
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.
Forward-Looking Statements:
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact : Dr. Kevin Buckman, CEO
Viratech Corp.
Email Contact: info@viratech.org